Relacation PM 10ml – 10 vials

Relacation PM (also referred to as Relaxation PM or Relax PM Blend in research contexts) is a compounded injectable research formulation designed as a nighttime relaxation and sleep-support blend, combining GABA (gamma-aminobutyric acid), melatonin, L-arginine, and L-glutamine in a sterile aqueous solution for subcutaneous or intramuscular administration. Typical per mL composition includes GABA 100 mg, Melatonin 1 mg, Arginine (L-arginine) 100 mg, and Glutamine (L-glutamine) 25 mg, often provided in 10 mL vials for research-grade use.
It functions through synergistic modulation of neurotransmitter systems, circadian regulation, and recovery pathways: GABA acts as the primary inhibitory neurotransmitter in the central nervous system, binding to GABA_A and GABA_B receptors to promote neuronal hyperpolarization, reduce excitability, calm racing thoughts, alleviate anxiety, and facilitate sleep onset and depth; melatonin, a pineal-derived hormone, regulates the sleep-wake cycle by signaling darkness to the suprachiasmatic nucleus, shortening sleep latency, enhancing sleep maintenance, and supporting restorative sleep stages; L-arginine serves as a precursor for nitric oxide (NO) synthesis via nitric oxide synthase, potentially improving cerebral and peripheral blood flow, reducing cortisol responses to stress, and enhancing relaxation through vasodilation and endothelial support; L-glutamine contributes to cellular energy (as a precursor for glutamate and GABA synthesis in certain contexts), supports muscle and gut recovery during rest, aids ammonia detoxification, and may bolster overall nighttime anabolic and reparative processes.
In preclinical and wellness research models (including studies on sleep induction, stress modulation, and recovery protocols), this blend is investigated for promoting deeper, more restorative sleep, reducing sleep latency and nighttime awakenings, attenuating stress/anxiety-related hyperarousal, supporting muscle recovery and immune function during rest, and optimizing circadian alignment without habit-forming properties typical of pharmaceutical sedatives. The injectable delivery bypasses gastrointestinal limitations for potentially improved bioavailability of GABA (which has debated oral CNS penetration) and melatonin, often enhanced by arginine’s role in NO-mediated blood-brain barrier permeability in some models. Relacation PM is utilized in research to investigate mechanisms of GABAergic inhibition combined with melatonergic signaling, nitric oxide pathways in relaxation and vascular support, amino acid synergies for sleep quality and recovery, neuroendocrine modulation of stress-sleep axes, supportive strategies for insomnia models, anxiety reduction, post-exercise or metabolic recovery, and the roles of these compounds in promoting neuronal calmness, circadian homeostasis, tissue repair, and overall restorative physiology during nocturnal periods.